Skip to content

SYRE

Spyre Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$97.33-2.89%

Price as of Jul 20, 2026

SYRE analysis

Spyre Therapeutics, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for SYRE is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research